Hotline:
+ 49 (0) 2204 2918806

Market studies for category Therapeutic Area

Items 1 to 10 of 4533 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 454
  1. Net price*
    Year
  2. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Myocardial Infarction – Pipeline Review, H1 2013

    Global Markets Direct
    235 pages
    Introduction Global Markets Direct’s, 'Myocardial Infarction - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Myocardial Infarction, complete with latest updates, and special features on late-stage and discontinued projects.
    Englisch | Report | SKU: 318594
  3. $2,000.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Fibromyalgia - Pipeline Review, H1 2015

    Global Markets Direct
    77 pages
    Global Markets Direct’s, ‘Fibromyalgia - Pipeline Review, H1 2015’, provides an overview of the Fibromyalgia’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Fibromyalgia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism
    Englisch | Zukunftsanalyse | SKU: 987678291
  4. $2,500.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Malignant Mesothelioma Global Clinical Trials Review, H1, 2014

    GlobalData
    149 pages
    GlobalData's clinical trial report, “Malignant Mesothelioma Global Clinical Trials Review, H1, 2014" provides data on the Malignant Mesothelioma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Malignant Mesothelioma. It includes an overview of the trial numbers and their re
    Englisch | Zukunftsanalyse | SKU: 402356
  5. $2,000.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Bronchiolitis – Pipeline Review, H2 2012

    Global Markets Direct
    58 pages
    Introduction Global Markets Direct’s, 'Bronchiolitis - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Bronchiolitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews
    Englisch | Pipeline Review | SKU: 317666
  6. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Dilated Cardiomyopathy - Pipeline Review, H2 2013

    Global Markets Direct
    60 pages
    Global Markets Direct’s, 'Dilated Cardiomyopathy - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Dilated Cardiomyopathy, complete with latest updates, and special features on late-stage and discontinued projects. It also rev
    Englisch | Zukunftsanalyse | SKU: 386176
  7. $2,000.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Chemotherapy Induced Nausea and Vomiting – Pipeline Review, H2 2012

    Global Markets Direct
    108 pages
    Introduction Global Markets Direct’s, 'Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Chemotherapy Induced Nausea and Vomiting, complete with latest updates, and special features on
    Englisch | Report | SKU: 318306
  8. $2,000.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2014

    Global Markets Direct
    141 pages
    Global Markets Direct’s, ‘Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2014’, provides an overview of the Bipolar Disorder (Manic Depression)’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Bipolar Disorder (Manic Depression), complete with comparative analysis
    Englisch | Zukunftsanalyse | SKU: 393836
  9. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Klebsiella Pneumoniae Infections – Pipeline Review, H1 2013

    Global Markets Direct
    46 pages
    Introduction Global Markets Direct’s, 'Klebsiella Pneumoniae Infections - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Klebsiella Pneumoniae Infections, complete with latest updates, and special features on late-stage and d
    Englisch | Report | SKU: 324452
  10. $2,000.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) - Pipeline Review, H1 2015

    Global Markets Direct
    55 pages
    Global Markets Direct’s, ‘Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) - Pipeline Review, H1 2015’, provides an overview of the Mucopolysaccharidosis II (MPS II) (Hunter Syndrome)’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Mucopolysaccharidosis II (MPS II) (Hunte
    Englisch | Zukunftsanalyse | SKU: 987680181
  11. $3,495.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Squalamine (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023

    GlobalData
    111 pages
    Macular Edema is a condition where fluid accumulates on the macula, leading to vision impairment or in severe cases even vision loss. The three main types of ME are diabetic macular edema (DME), and macular edema following either a central or branch retinal vein occlusion (ME-CRVO and ME-BRVO). Age-related macular degeneration (AMD) is a
    Englisch | Zukunftsanalyse | SKU: 987678518

Items 1 to 10 of 4533 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 454